Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein

Phytomedicine

Volumn 16, Issue 12, 2009, Pages 1095-1100

  Romiti, Nadia ^a   Tramonti, Gianfranco ^a   Corti, Alessandro ^a   Chieli, Elisabetta ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

ABCB1; Devil's Claw (Harpagophytum procumbens); Harpagoside; HK 2 cells; P glycoprotein

Indexed keywords

GLYCOPROTEIN P; HARPAGOPHYTUM PROCUMBENS EXTRACT; HARPAGOSIDE; MULTIDRUG RESISTANCE PROTEIN 1;

ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; HUMAN; HUMAN CELL; KIDNEY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BLOTTING, WESTERN; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOSIDES; HARPAGOPHYTUM; HERB-DRUG INTERACTIONS; HUMANS; KIDNEY; P-GLYCOPROTEIN; PHYTOTHERAPY; PLANT EXTRACTS; PYRANS; UP-REGULATION;

HARPAGOPHYTUM PROCUMBENS;

EID: 70350590858     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.05.001     Document Type: Article

References (31)

1. Abdelouahab N., and Heard C. Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro. J. Nat. Prod. 71 (2008) 746-749
2. Adams M., Mahringer A., Kunert O., Fricker G., Efferth T., and Bauer R. Cytotoxicity and P-glycoprotein modulating effects of quinolones and indoloquinazolines from the Chinese herb Evodia rutaecarpa. Planta. Med. 73 (2007) 1554-1557
3. Angelini A., Iezzi M., Di Febbo C., Di Ilio C., Cuccurullo F., and Porreca E. Reversal of P-glycoprotein-mediated multidrug resistance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs. Oncol. Rep. 20 (2008) 731-735
4. Aszalos A. Role of the ATP-binding cassette (ABC) transporters in interactions between natural products and drugs. Curr. Drug Metab. 9 (2008) 1010-1018
5. Betancor-Fernández A., Pérez-Gálvez A., Sies H., and Stahl W. Screening pharmaceuticals preparations containing extracts of turmeric rhizome, artichoke leaf, devil's claw root and garlic or salmon oil for antioxidant capacity. J. Pharm. Pharmacol. 55 (2003) 981-986
6. Chieli E., and Romiti N. Kidney proximal human tubule HK-2 cell line as a tool for the investigation of P-glycoprotein modulation by natural compounds. Bol. Latinoam. Caribe Plant. Med. Aromaticas 7 (2008) 282-295
7. Gillet J.P., Efferth T., and Remacle J. Chemotherapy-induced resistance by ATP-binding cassette transporter genes. Biochim. Biophys. Acta 1775 (2007) 237-262
8. Grant L., McBean D.E., Fyfe L., and Warnock A.M. A review of the biological and potential therapeutic actions of Harpagophytum procumbens. Phytother. Res. 21 (2007) 199-209
9. Harpagophytum procumbens (devil's claw). Monograph, 2008. Altern. Med. Rev. 13, 248-252.
10. Holló Z., Homolya L., Davis C.W., and Sarkadi B. Calcein accumulation as a fluorometric functional assay of the multidrug transporter. Biochim. Biophys. Acta 1191 (1994) 384-388
11. Hu Z., Yang X., Ho P.C., Chan S.Y., Heng P.W., Chan E., Duan W., Koh H.L., and Zhou S. Herb-drug interactions: a literature review. Drugs 65 (2005) 1239-1282
12. Huang T.H., Tran V.H., Duke R.K., Tan S., Chrubasik S., Roufogalis B.D., and Duke C.C. Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kappa B activation. J. Ethnopharmacol. 104 (2006) 149-155
13. Huang L., Wang C., Zheng W., Liu R., Yang J., and Tang C. Effects of celecoxib on the reversal of multidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P-glycoprotein. Anticancer Drugs 18 (2007) 1075-1080
14. Izzo A.A. Herb-drug interactions: an overview of the clinical evidence. Fundam. Clin. Pharmacol. 19 (2005) 1-16
15. Kaszkin M., Beck K.F., Koch E., Erdelmeier C., Kusch S., Pfeilschifter J., and Loew D. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects. Phytomedicine 11 (2004) 585-595
16. Leslie E.M., Deeley R.G., and Cole S.P. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol. Appl. Pharmacol. 204 (2005) 216-237
17. Li P., Callery P.S., Gan L.S., and Balani S.K. Esterase inhibition by grapefruit juice flavonoids leading to a new drug interaction. Drug Metab. Dispos. 35 (2007) 1203-1208
18. Marchetti S., Mazzanti R., Beijnen J.H., and Schellens J.H. Concise review: clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein). Oncologist 12 (2007) 927-941
19. Pal D., and Mitra A.K. MDR- and CYP3A4-mediated drug-herbal interactions. Life Sci. 78 (2006) 2131-2145
20. Qi J., Chen J.J., Cheng Z.H., Zhou J.H., Yu B.Y., and Qiu S.X. Iridoid glycosides from Harpagophytum procumbens D.C. (devil's claw). Phytochemistry 67 (2006) 1372-1377
21. Romiti N., Tramonti G., Donati A., and Chieli E. Effects of grapefruit juice on the multidrug transporter P-glycoprotein in the human proximal tubular cell line HK-2. Life Sci. 76 (2004) 293-302
22. Romiti N., Pellati F., Nieri P., Benvenuti S., Adinolfi B., and Chieli E. P-glycoprotein inhibitory activity of lipophilic constituents of Echinacea pallida roots in a human proximal tubular cell line. Planta. Med. 74 (2008) 1-3
23. Sagare A.P., Kuo C.L., Chueh F.S., and Tsay H.S. De novo regeneration of Scrophularia yoshimurae Yamazaki (Scrophulariaceae) and quantitative analysis of harpagoside, an iridoid glucoside, formed in aerial and underground parts of in vitro propagated and wild plants by HPLC. Biol. Pharm. Bull. 24 (2001) 1311-1315
24. Tundis R., Loizzo M.R., Menichini F., Statti G.A., and Menichini F. Biological and pharmacological activities of iridoids: recent developments. Mini Rev. Med. Chem. 8 (2008) 399-420
25. Setty A.R., and Sigal L.H. Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects. Semin. Arthritis Rheum. 34 (2005) 773-784
26. Unger M., and Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun. Mass Spectrom. 18 (2004) 2273-2281
27. Varma M.V., Ashokraj Y., Dey C.S., and Panchagnula R. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol. Res. 48 (2003) 347-359
28. Vlachojannis J., Roufogalis B.D., and Chrubasik S. Systematic review on the safety of Harpagophytum preparations for osteoarthritic and low back pain. Phytother. Res. 22 (2008) 149-152
29. Warnock M., McBean D., Suter A., Tan J., and Whittaker P. Effectiveness and safety of Devil's Claw tablets in patients with general rheumatic disorders. Phytother. Res. 21 (2007) 1228-1233
30. Williamson E.M. Interactions between herbal and conventional medicines: the role of cytochrome P450 enzymes and P-glycoprotein. Pharmacologyonline 2 (2006) 200-205
31. Zhou S., Lim L.Y., and Chowbay B. Herbal modulation of P-glycoprotein. Drug Metab. Rev. 36 (2004) 57-104